Altium Capital Management LP Genprex, Inc. Transaction History

Altium Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.11 - $4.87 $189,426 - $296,626	-60,909 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$3.66 - $7.67 $4.94 Million - $10.3 Million	-1,348,876 Reduced 95.68%	60,909 $263,000
Q4 2020 Feb 16, 2021	BUY	$3.03 - $5.51 $4.27 Million - $7.77 Million	1,409,785 New	1,409,785 $5.85 Million

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $112M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.